The mutation profiles of common oncogenes involved in melanoma in southern China

Journal of Investigative Dermatology

Volumn 132, Issue 7, 2012, Pages 1935-1937

  Zhou, Qi Ming ^a   Li, Wei ^b   Zhang, Xing ^a   Chen, Yin Bo ^a   Chen, Xin Chun ^b   Guan, Yuan Xiang ^a   Ding, Ya ^a   Wen, Xi Zhi ^a   Xia, Qing ^a   Zhou, Qiang ^a   Peng, Rui Qing ^a   Hou, Jin Hui ^a   Zhu, Xiao Feng ^a   Zeng, Yi Xin ^a   Zhang, Xiao Shi ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CARCINOGENESIS; CHINA; GENE MUTATION; GENE TECHNOLOGY; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LETTER; LYMPH NODE METASTASIS; MELANOMA; ONCOGENE; PRIORITY JOURNAL;

EID: 84862800045     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.64     Document Type: Letter

References (11)

1. Casula M, Muggiano A, Cossu A et al. (2009) Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy. BMC Cancer 9:352
2. Chang YL, Wu CT, Shih JY et al. (2011) Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers. Ann Surg Oncol 18:543-50
3. Chapman PB, Hauschild A, Robert C et al. (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507-16
4. Cui Q (2010) A network of cancer genes with co-occurring and anti-co-occurring mutations. PLoS One 5:pii: e13180
5. Han HS, Eom DW, Kim JH et al. (2011) EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clin Lung Cancer 12:380-6
6. Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302-12
7. Kong Y, Si L, Zhu Y et al. (2011) Large-scale analysis of KIT aberrations in Chinese patients with melanoma. Clin Cancer Res 17:1684-91
8. Lee JH, Choi JW, Kim YS (2011) Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol 164:776-84
9. Patel SP, Kim KB, Papadopoulos NE et al. (2011) A phase II study of gefitinib in patients with metastatic melanoma. Melanoma Res 21:357-63
10. Qi RQ, He L, Zheng S et al. (2011) BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. J Invest Dermatol 131:1129-38
11. Schmidt-Kittler O, Ragg T, Daskalakis A et al. (2003) From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 100:7737-42 (Pubitemid 36760039)